185 related articles for article (PubMed ID: 16051745)
1. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.
Glud SZ; Sørensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS
Blood; 2005 Nov; 106(10):3546-52. PubMed ID: 16051745
[TBL] [Abstract][Full Text] [Related]
2. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
3. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
4. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.
Sørensen AB; Lund AH; Ethelberg S; Copeland NG; Jenkins NA; Pedersen FS
J Virol; 2000 Mar; 74(5):2161-8. PubMed ID: 10666245
[TBL] [Abstract][Full Text] [Related]
5. Activation of an oncogenic microRNA cistron by provirus integration.
Wang CL; Wang BB; Bartha G; Li L; Channa N; Klinger M; Killeen N; Wabl M
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18680-4. PubMed ID: 17121985
[TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice.
Panoutsakopoulou V; Hunter K; Sieck TG; Blankenhorn EP; Blank KJ
J Virol; 1999 Nov; 73(11):9232-6. PubMed ID: 10516031
[TBL] [Abstract][Full Text] [Related]
7. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
Ethelberg S; Tzschaschel BD; Luz A; Diaz-Cano SJ; Pedersen FS; Schmidt J
J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
[TBL] [Abstract][Full Text] [Related]
8. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells, apoptosis and murine retrovirus.
Woods GM; Gabrilovich DI; Elsley W; English N; Knight SC
Adv Exp Med Biol; 1995; 378():493-6. PubMed ID: 8526126
[No Abstract] [Full Text] [Related]
10. Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.
Avidan N; Sieck TG; Blank KJ
Clin Immunol Immunopathol; 1997 Dec; 85(3):282-8. PubMed ID: 9400628
[TBL] [Abstract][Full Text] [Related]
11. Cuttine edge: T cells from aged mice are resistant to depletion early during virus infection.
Jiang J; Anaraki F; Blank KJ; Murasko DM
J Immunol; 2003 Oct; 171(7):3353-7. PubMed ID: 14500628
[TBL] [Abstract][Full Text] [Related]
12. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
13. High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas.
Beaty RM; Rulli K; Bost KL; Pantginis J; Lenz J; Levy LS
Virology; 1999 Sep; 261(2):253-62. PubMed ID: 10497110
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
15. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
16. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of theophylline: modulation of immune functions during murine leukemia virus infection.
Liang B; Jiang S; Zhang Z; Inserra P; Lee J; Solkoff D; Watson RR
Immunopharmacol Immunotoxicol; 2001 Aug; 23(3):307-19. PubMed ID: 11694023
[TBL] [Abstract][Full Text] [Related]
18. The role of the immune response in MULV-induced lymphomagenesis.
Marshall DJ; Gaulton GN
Leukemia; 1996 Dec; 10(12):1860-6. PubMed ID: 8946922
[TBL] [Abstract][Full Text] [Related]
19. Identification of a common site of provirus integration in radiation leukemia virus-induced T-cell lymphomas in mice.
Lambert J; Bergeron D; Kozak CA; Rassart E
Virology; 1999 Nov; 264(1):181-6. PubMed ID: 10544143
[TBL] [Abstract][Full Text] [Related]
20. Non-identical patterns of proviral insertions around host transcription units in lymphomas induced by different strains of murine leukemia virus.
Martín-Hernández J; Balle Sørensen A; Pedersen FS
Virology; 2006 Sep; 353(1):193-9. PubMed ID: 16790256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
